Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Journal of Clinical and Translational Science
ISSN 2059-8661 · Cambridge University Press · United Kingdom
Journal of Clinical and Translational Science: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.7 (journal website); fully open access; APC about USD 2,925; median 159 days to acceptance (93 articles, last 24 months); 751 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Clinical and Translational Science is published by Cambridge University Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health and Medical Research Impacts, Health Policy Implementation Science and Ethics in Clinical Research, together about 37.8% of its articles. Its main subfields are General Health Professions. (generated from OpenAlex topic counts and CAS ranking data)
The mission of the Journal of Clinical and Translational Science (JCTS) is to provide a forum for disseminating advances in clinical and translational science. JCTS, the official journal of the Association for Clinical and Translational Science and the Clinical Research Forum, is a fully Open Access journal publishing high-quality articles on research that spans the translational continuum, as well as education research that informs the development of the translational workforce. Topics of interest include investigations into how to best develop processes and people that translate discoveries into improved health. The Association for Clinical and Translational Science has partnered with the Clinical Research Forum (CRF) to support the growth and development of JCTS. The Journal's founding Editor is Arthur M. Feldman, MD, PhD.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Christopher J. LindsellPublisher website
Editorial board by country: none in mainland China; most named United States 38 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health and Medical Research ImpactsMedicine19.2%
- Health Policy Implementation ScienceHealth Professions10.5%
- Ethics in Clinical ResearchMedicine8.1%
- Biomedical and Engineering EducationEngineering8%
- Health Sciences Research and EducationHealth Professions7.8%
- Interdisciplinary Research and CollaborationDecision Sciences6.7%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance3.6%
- Mental Health and Patient InvolvementHealth Professions3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 3.2LetPub ·
- SJR 2026-06
- 0.97LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 374OpenAlex ·
- 2-year mean citedness
- 0.68OpenAlex ·
- Self-citation rate
- 18.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 239LetPub ·
Articles by year OpenAlex count · 5,332 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 583 | 583 | 20 |
| 2025 | 751 | 751 | 448 |
| 2024 | 692 | 692 | 908 |
| 2023 | 649 | 649 | 1,970 |
| 2022 | 468 | 468 | 1,286 |
| 2021 | 518 | 518 | 2,746 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
159 daysMedian, submission to acceptance · P25–P75 114 days – 197 days
- Acceptance to online
- median 16 days (94 articles)
- Submission to online
- median 175 days
- Sample
- 93 articles with submission and acceptance dates (505 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 18 weeksLetPub ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,925 / GBP 2,320 | Yes | CC BY, CC BY-NC-SA, CC BY-NC-ND | |
| OpenAlex | USD 3,200 / GBP 2,516 | — | — | |
| LetPub | GBP 2,320 / USD 2,925 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted16
- accepted research articlesAccepted Research Articles*Length not stated
- brief reportResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- brief reportsBrief Reports*Length not stated
- case studyResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- conference paperResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- editorialResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- editorialsEditorialsLength not stated
- letterResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- lettersLettersLength not stated
- perspectiveResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- perspectivesPerspectivesLength not stated
- research articleResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- review articleResearch Articles* Brief Reports* Letters Special Communications* Review Articles* Editorials Perspectives Conference Paper Translational Science Case Studies*Length not stated
- review articlesReview Articles*Length not stated
- special communicationsSpecial Communications*Length not stated
- translational science case studiesTranslational Science Case Studies*Length not stated
Policy excerpts from the journal's websiteAI use
- AI use The role of Generative AI in advancing community engagement to address health inequities: a scoping review
Abby M. Lohr, Emily J. Sabey, Chenyu Gai, Larry Prokop, Matthew J. Spiten, Lisa G. Rosas, Ting Pun, Suganya Karuppana, Shauna M. Overgaard, M. Hassan Murad, Sagar B. Dugani, Mark L. Wieland
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Cambridge University Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2059-8661
- Society / sponsor
- ACTS and CR Forum
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Clinical and Translational Science
What CAS zone is Journal of Clinical and Translational Science in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical and Translational Science is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical and Translational Science?
The journal's website gives an impact factor of 2.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.2, h-index 46.
How long does peer review take at Journal of Clinical and Translational Science?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 159 days (interquartile range 114–197 days); authors report an average review time of about 18 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Clinical and Translational Science based?
Of the 38 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (38). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Clinical and Translational Science?
According to LetPub and DOAJ records, Journal of Clinical and Translational Science is indexed in ESCI, Scopus and DOAJ.
Is Journal of Clinical and Translational Science open access, and what is the APC?
Journal of Clinical and Translational Science is a fully open-access journal. APC about USD 2,925.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .